Clinical Trial Update: Relugolix + Enzalutamide Study in High-Risk Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of Relugolix and Enzalutamide for high-risk locally advanced prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Relugolix (Relugolix)

Snippet

Sponsor: University of Oklahoma | Conditions: Androgen Deprivation Therapy, Locally Advanced Prostate Cancer | Phase 1 | Status: RECRUITING